-
1.发明授权Manual processing systems and methods for providing blood components conditioned for pathogen inactivation 有权用于提供为病原体灭活而调节的血液成分的手动处理系统和方法公开(公告)号：US07264608B2
公开(公告)日：2007-09-04
申请号：US10008361
申请日：2001-12-05
CPC分类号： A61M1/3681 , A01N1/02 , A01N1/0215 , A01N1/0263 , A61M1/0222 , A61M1/0231 , A61M1/0272 , A61M1/0281 , A61M1/3683
摘要： Systems and methods manually process blood and blood components in sterile, closed environments, which further condition the blood components for subsequent pathogen inactivation processes. The systems and methods mate the manual collection of random donor platelet units with the creation of larger therapeutic doses of platelets targeted to undergo pathogen inactivation prior to long term storage and/or transfusion.
摘要翻译： 系统和方法在无菌，封闭的环境中手动处理血液和血液成分，这进一步调节血液成分以用于随后的病原体灭活过程。 系统和方法将随机供体血小板单元的手动收集与在长期储存和/或输血之前进行病原体灭活的较大治疗剂量的血小板相匹配。
-
公开(公告)号：US06936413B1
公开(公告)日：2005-08-30
申请号：US10004696
申请日：2001-12-05
申请人： Daniel F. Bischof , Ying-Cheng Lo
发明人： Daniel F. Bischof , Ying-Cheng Lo
CPC分类号： A61M1/3681 , A61M1/3683
摘要： Methods and systems for preparing blood products that are ready for treatment in established pathogen inactivation procedures are disclosed. The methods include providing a source of a blood component and combining the blood component with a synthetic medium in a selected ratio of the blood component to the synthetic media, whereby the resulting blood product is treatment-ready.
摘要翻译： 公开了用于制备在已建立的病原体灭活程序中进行治疗的血液制品的方法和系统。 所述方法包括提供血液成分来源并以所选择的血液成分与合成培养基的比例将血液成分与合成培养基结合，由此所得到的血液制品是待处理的。
-
公开(公告)号：US09821105B2
公开(公告)日：2017-11-21
申请号：US12166063
申请日：2008-07-01
申请人： Rosa H. Yeh , Wei Xie , Hsinjin E. Yang , Michael T. K. Ling , Ying-Cheng Lo
发明人： Rosa H. Yeh , Wei Xie , Hsinjin E. Yang , Michael T. K. Ling , Ying-Cheng Lo
CPC分类号： A61M1/3486 , A61M1/14 , A61M1/16 , A61M1/1619 , A61M1/1696 , A61M1/28 , A61M1/284 , A61M1/34 , A61M1/3406 , A61M1/3413 , A61M1/3472 , A61M2202/0498 , A61M2205/0211 , A61M2205/12 , A61M2205/125 , A61M2205/126 , A61M2205/15 , A61M2205/3331 , A61M2205/3368 , A61M2205/50 , A61M2205/75 , A61M2209/088
摘要： Dialysis is enhanced by using nanoclay sorbents to better absorb body wastes in a flow-through system. The nanoclay sorbents, using montmorillonite, bentonite, and other clays, absorb significantly more ammonium, phosphate, and creatinine, and the like, than conventional sorbents. The montmorillonite, the bentonite, and the other clays may be used in wearable systems, such as a wearable peritoneal dialysis system, in which a dialysis fluid is circulated through a filter with the nanoclay sorbents. Waste products are absorbed by the montmorillonite, the bentonite, and the other clays and the dialysis fluid is recycled to a patient's peritoneum. Using an ion-exchange capability of the montmorillonite, the bentonite, and the other clays, waste ions in the dialysis fluid are replaced with desirable ions, such as calcium, magnesium, and bicarbonate. The nanoclay sorbents are also useful for refreshing a dialysis fluid used in hemodialysis and thus reducing a quantity of the dialysis fluid needed for the hemodialysis.
-
公开(公告)号：US08936720B2
公开(公告)日：2015-01-20
申请号：US13195376
申请日：2011-08-01
申请人： Robert W. Childers , Ying-Cheng Lo , Peter Hopping
发明人： Robert W. Childers , Ying-Cheng Lo , Peter Hopping
摘要： The present system and method in one embodiment limit a maximum instantaneous peritoneal volume to a comfortable level, while allowing the dialysis machine to advance to fill a prescribed volume whenever the drain ends after a minimum drain percentage has been attained. If a low drain condition occurs, the nominal fill volume is lowered and a therapy cycle is added, so that a prescribed total amount of fresh therapy fluid is used during therapy, maximizing therapeutic benefit. An allowable residual volume at the end of an incomplete drain is increased, thereby lowering the probability of a subsequent low drain condition.
摘要翻译： 在一个实施例中，本系统和方法将最大瞬时腹膜容积限制到舒适水平，同时每当排水终点达到最小排水百分比后，允许透析机前进以填充规定的体积。 如果发生低排泄状况，则标称填充体积降低并加入治疗周期，使得在治疗期间使用规定的总量的新鲜治疗液，使治疗效果最大化。 在不完全排水结束时允许的剩余体积增加，从而降低随后的低排放条件的可能性。
-
公开(公告)号：US08926540B2
公开(公告)日：2015-01-06
申请号：US13213812
申请日：2011-08-19
CPC分类号： A61M1/1639 , A61M1/16 , A61M1/1603 , A61M1/1605 , A61M1/1635 , A61M1/166 , A61M1/28 , A61M1/284 , A61M1/34 , A61M1/3627 , A61M2205/127 , A61M2205/3331 , A61M2205/3368 , A61M2205/502 , Y10T29/49826
摘要： A hemodialysis system includes (i) a dialyzer; (ii) a blood pump; (iii) a blood cassette operatively connected to the dialyzer and the blood pump; (iv) a dialysate heater; (v) first and second peristaltic dialysate pumps; and (vi) a dialysate cassette separate from the blood cassette, the dialysate cassette including an organizer configured to support a drain tube, a to-dialyzer tube and a from-dialyzer tube, the cassette further including a first pumping tube, a second pumping tube and an inline fluid heating pathway, the cassette when mounted for operation orienting (a) the first pumping tube for operation with the first peristaltic dialysate pump, (b) the second pumping tube for operation with the second peristaltic dialysate pump and (c) the fluid heating pathway for operation with the dialysate heater.
摘要翻译： 血液透析系统包括（i）透析器; （ii）血液泵; （iii）可操作地连接到透析器和血液泵的血盒; （iv）透析液加热器; （v）第一和第二蠕动透析液泵; 和（vi）与血液盒分离的透析盒，所述透析液盒包括构造成支撑排液管，透析器管和透析器管的组织器，所述盒还包括第一泵管，第二抽吸 管和管线流体加热通道，当安装用于操作时的盒子定向（a）用于与第一蠕动透析泵一起操作的第一泵管，（b）用于与第二蠕动透析泵一起操作的第二泵管，以及（c） 用于与透析液加热器一起操作的流体加热路径。
-
6.发明授权Hemodialysis and peritoneal dialysis systems having electrodeionization capabilities 有权血液透析和具有电去离子能力的腹膜透析系统公开(公告)号：US08858792B2
公开(公告)日：2014-10-14
申请号：US12718609
申请日：2010-03-05
申请人： Yuanpang Samuel Ding , Ying-Cheng Lo , Joshua James Miller , Justin Rohde , Sujatha Karoor , Stephane Dupont
发明人： Yuanpang Samuel Ding , Ying-Cheng Lo , Joshua James Miller , Justin Rohde , Sujatha Karoor , Stephane Dupont
CPC分类号： A61M1/1696 , A61M1/1674 , A61M1/28 , A61M1/284 , A61M1/287 , A61M2202/0014 , B01D61/243 , B01D61/44 , B01D61/58
摘要： Systems and methods for hemodialysis or peritoneal dialysis having integrated electrodeionization capabilities are provided. In an embodiment, the dialysis system includes a carbon source, a urease source and an electrodeionization unit. The carbon source and urease source can be in the form of removable cartridges.
摘要翻译： 提供了具有集成的电去离子能力的用于血液透析或腹膜透析的系统和方法。 在一个实施方案中，透析系统包括碳源，脲酶源和电去离子单元。 碳源和脲酶源可以是可移除的盒的形式。
-
公开(公告)号：US20120215159A1
公开(公告)日：2012-08-23
申请号：US13458625
申请日：2012-04-27
IPC分类号： A61M1/28
摘要： A system and method for automatically adjusting a Continuous Cycling Peritoneal Dialysis (“CCPD”) therapy to minimize the potential for excess intra-peritoneal volume. The adjustments are made at the end of the drain, just prior to the next fill. The adjustments short the next fill, if necessary, to limit the intra-peritoneal volume, add a cycle, if necessary, to use all of the available dialysis solution and will average the remaining dwell time to maximize the therapeutic benefit of the therapy in the allotted time. In another embodiment, a tidal therapy using trended patient UF data is provided.
摘要翻译： 一种用于自动调节连续循环腹膜透析（“CCPD”）治疗的系统和方法，以最大限度地减少腹膜内多余的体积。 调整是在排水结束时进行的，就在下一次填充之前。 如果需要，调整缩短下一次填充，以限制腹膜内体积，如果需要，添加一个循环，以使用所有可用的透析溶液，并将平均剩余停留时间，以最大化治疗的治疗效果 分配时间 在另一个实施例中，提供使用趋势化患者UF数据的潮汐治疗。
-
公开(公告)号：US08182673B2
公开(公告)日：2012-05-22
申请号：US12362259
申请日：2009-01-29
IPC分类号： B01D61/32
摘要： A system and method for automatically adjusting a Continuous Cycling Peritoneal Dialysis (“CCPD”) therapy to minimize the potential for excess intra-peritoneal volume. The adjustments are made at the end of the drain, just prior to the next fill. The adjustments short the next fill, if necessary, to limit the intra-peritoneal volume, add a cycle, if necessary, to use all of the available dialysis solution and will average the remaining dwell time to maximize the therapeutic benefit of the therapy in the allotted time. In another embodiment, a tidal therapy using trended patient UF data is provided.
摘要翻译： 一种用于自动调节连续循环腹膜透析（“CCPD”）治疗的系统和方法，以最大限度地减少腹膜内多余的体积。 调整是在排水结束时进行的，就在下一次填充之前。 如果需要，调整缩短下一次填充，以限制腹膜内体积，如果需要，添加一个循环，以使用所有可用的透析溶液，并将平均剩余停留时间，以最大化治疗的治疗效果 分配时间 在另一个实施例中，提供使用趋势化患者UF数据的潮汐治疗。
-
9.发明申请公开(公告)号：US20110093294A1
公开(公告)日：2011-04-21
申请号：US12826183
申请日：2010-06-29
CPC分类号： A61M1/28 , A61M2205/3553 , A61M2205/3569 , A61M2205/3592 , A61M2205/52 , A61M2205/6072 , G06F19/00 , G06F19/3481 , G06Q50/24 , G16H10/65
摘要： A dialysis system includes: a portable device configured to be carried by a patient and to read a marking displayed on a dialysis fluid container, the device obtaining data concerning at least one of a dialysis fluid type and a dialysis fluid volume from the marking; the device defined dialysate dwell time, alert patients for the next exchange and further configured to transfer the data to a computer; and wherein the computer is configured to use the data to track therapy progress of the product.
摘要翻译： 透析系统包括：便携式装置，其被配置为由患者携带并读取透析液容器上显示的标记，所述装置从所述标记获得关于透析液类型和透析液体积中的至少一种的数据; 设备定义了透析剂停留时间，为下一次交换提醒患者，并进一步配置为将数据传输到计算机; 并且其中所述计算机被配置为使用所述数据来跟踪所述产品的治疗进展。
-
公开(公告)号：US20110048949A1
公开(公告)日：2011-03-03
申请号：US12548876
申请日：2009-08-27
CPC分类号： A61M1/1696 , A61M1/284 , A61M1/287 , A61M2209/088
摘要： Dialysis treatment devices and methods for removing urea from dialysis waste streams are provided. In a general embodiment, the present disclosure provides a dialysis treatment device including a first cell having a first electrodialysis unit, a second cell having at least one of a urease compartment and a sorbent compartment and in fluid communication with the first cell, and a third cell having a second electrodialysis unit and in fluid communication with the second cell.
摘要翻译： 提供了用于从透析废物流中除去尿素的透析治疗装置和方法。 在一般实施方案中，本公开提供了一种透析治疗装置，其包括具有第一电渗析装置的第一细胞，具有尿素酶隔室和吸附剂隔室中的至少一个并与第一细胞流体连通的第二细胞， 电池具有第二电渗析单元并与第二电池流体连通。
-
-
-
-
-
-
-
-
-
搜索结果
83 条记录 (耗时 0.032 秒)
